ZBIO Q1 2025 Earnings — Zenas BioPharma, Inc. Revenue & Financial Results | Market Cap Arena

ZBIOZenas BioPharma, Inc.

$1B

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M

Gross Profit

$10M100.0% margin

Operating Income

-$37M-373.3% margin

Net Income

-$34M-335.7% margin

EPS (Diluted)

$-0.80

QoQ Revenue Growth

+100.0%

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$37M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$334M

Total Liabilities

$49M

Stockholders' Equity

$284M

Cash & Equivalents

$197M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$0	—
Gross Profit	$10M	-$23M	+144.2%
Operating Income	-$37M	-$28M	-35.4%
Net Income	-$34M	-$28M	-20.8%